Related Experiment Video
Updated: Nov 29, 2025
05:15
Viral Transgene Expression in Rodent Hearts and the Assessment of Cardiac Arrhythmia Risk
Published on: July 27, 2022
1.9K
Hantavirus Cardiopulmonary Syndrome in Canada
Emerging Infectious Diseases
|November 21, 2020
Summary
Hantavirus cardiopulmonary syndrome (HCPS) is a severe respiratory illness in North America caused by Sin Nombre virus (SNV). In Canada, SNV has caused 143 HCPS cases, prompting a review of its epidemiology, ecology, biology, and genetics.
Area of Science:
- * Infectious Disease Epidemiology
- * Viral Ecology and Genetics
- * Public Health Microbiology
Background:
- * Hantavirus cardiopulmonary syndrome (HCPS) is a severe, often fatal, respiratory disease.
- * Sin Nombre virus (SNV) is the primary North American hantavirus responsible for HCPS.
- * As of January 1, 2020, 143 laboratory-confirmed HCPS cases linked to SNV were reported in Canada.
Purpose of the Study:
- * To review critical aspects of SNV epidemiology in Canada.
- * To examine the ecological, biological, and genetic factors influencing HCPS in the Canadian context.
Main Methods:
- * Literature review and synthesis of existing data on SNV and HCPS in Canada.
- * Analysis of epidemiological trends and case data.
- * Review of ecological, biological, and genetic studies relevant to SNV.
Main Results:
- * SNV is established as a significant cause of HCPS in Canada, with 143 confirmed cases by early 2020.
- * The review synthesizes current knowledge on SNV transmission dynamics, host-virus interactions, and genetic diversity.
- * Key factors influencing SNV prevalence and HCPS incidence in Canada are identified.
Conclusions:
- * Understanding SNV epidemiology, ecology, biology, and genetics is crucial for managing HCPS in Canada.
- * Continued surveillance and research are necessary to mitigate the impact of SNV-associated HCPS.
- * This review provides a comprehensive overview to inform public health strategies.
Keywords:
CanadaSin Nombre virushantavirushantavirus cardiopulmonary syndromehantavirus pulmonary syndrome hantavirusvirusesMore Related Videos
13:12Quantitative Analyses of all Influenza Type A Viral Hemagglutinins and Neuraminidases using Universal Antibodies in Simple Slot Blot Assays
Published on: April 4, 2011
18.6K
07:49Large-Animal Model of Donation after Circulatory Death and Normothermic Regional Perfusion for Cardiac Assessment
Published on: May 10, 2022
1.9K
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
198
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
198
01:30Cardiomyopathy II: Dilated Cardiomyopathy
229
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
229
01:29Cardiomyopathy V: Interprofessional Care
147
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
147
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
271
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
271
01:25Cardiomyopathy I: Introduction and Classification
324
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
324
01:29Cardiomyopathy VI: Nursing Management
179
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
179